Aurobindo Pharma Limited has informed the Exchange regarding a press release dated October 23, 2023, titled "Eugia Pharma receives USFDA approval for Testosterone Cypionate Injection".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated October 23, 2023, titled "Eugia Pharma receives USFDA approval for Testosterone Cypionate Injection".